4-678670-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002477.2(MYL5):āc.16A>Gā(p.Thr6Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000833 in 1,609,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002477.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152248Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000549 AC: 13AN: 236630Hom.: 0 AF XY: 0.0000465 AC XY: 6AN XY: 128958
GnomAD4 exome AF: 0.0000796 AC: 116AN: 1456692Hom.: 0 Cov.: 33 AF XY: 0.0000815 AC XY: 59AN XY: 724224
GnomAD4 genome AF: 0.000118 AC: 18AN: 152366Hom.: 0 Cov.: 34 AF XY: 0.000107 AC XY: 8AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.16A>G (p.T6A) alteration is located in exon 2 (coding exon 2) of the MYL5 gene. This alteration results from a A to G substitution at nucleotide position 16, causing the threonine (T) at amino acid position 6 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at